Scott Takara A, Babayeva Oguljahan, Banerjee Saswati, Zhong Wei, Francis Sharon C
Department of Physiology, Morehouse School of Medicine, Atlanta, Georgia, USA.
Cardiovascular Research Institute, Morehouse School of Medicine, Atlanta, Georgia, USA.
Obesity (Silver Spring). 2016 Mar;24(3):678-86. doi: 10.1002/oby.21425. Epub 2016 Feb 1.
Enhanced serum and glucocorticoid-inducible kinase 1 (SGK1) activity contributes to the pathogenesis of vascular disease. This study evaluated SGK1 modulation in vascular smooth muscle cells by the adipokine resistin and in aortic tissue in a murine model of diet-induced obesity (DIO).
Modulation of SGK1 by resistin was assessed in human aortic smooth muscle cells (HAoSMC) in vitro by quantitative RT-PCR and Western blot analyses. To induce the lean or obese phenotype, mice were fed a 10 kcal% low-fat or 60 kcal% high-fat diet, respectively, for 8 weeks. Upon study completion, plasma resistin was assessed and aortic tissue was harvested to examine the effect of DIO on regulation of SGK1 in vivo.
Resistin increased SGK1 mRNA, total protein abundance, and its activation as determined by phosphorylation of its serine 422 residue (pSGK1) in HAoSMC. Resistin-mediated SGK1 phosphorylation was dependent upon phosphatidylinositol-3-kinase and Toll-like receptor 4. Furthermore, inhibition of SGK1 attenuated resistin-induced proliferation in HAoSMC. DIO led to up-regulation of total SGK1 protein levels and pSGK1 in association with increased plasma resistin.
These data suggest that high levels of resistin observed during obesity may activate SGK1 in the vasculature and contribute to the development of obesity-related vascular disease.
血清和糖皮质激素诱导激酶1(SGK1)活性增强与血管疾病的发病机制有关。本研究评估了在饮食诱导肥胖(DIO)小鼠模型中,脂肪因子抵抗素对血管平滑肌细胞中SGK1的调节作用以及对主动脉组织的影响。
通过定量逆转录聚合酶链反应(RT-PCR)和蛋白质免疫印迹分析,在体外评估人主动脉平滑肌细胞(HAoSMC)中抵抗素对SGK1的调节作用。为诱导瘦型或肥胖型表型,分别给小鼠喂食10千卡%的低脂或60千卡%的高脂饮食,持续8周。研究结束后,评估血浆抵抗素水平,并采集主动脉组织,以检查DIO对体内SGK1调节的影响。
抵抗素增加了HAoSMC中SGK1的信使核糖核酸(mRNA)、总蛋白丰度及其活性,活性通过其丝氨酸422残基的磷酸化(pSGK1)来确定。抵抗素介导的SGK1磷酸化依赖于磷脂酰肌醇-3-激酶和Toll样受体4。此外,抑制SGK1可减弱抵抗素诱导的HAoSMC增殖。DIO导致总SGK1蛋白水平和pSGK1上调,同时血浆抵抗素增加。
这些数据表明,肥胖期间观察到的高水平抵抗素可能激活血管中的SGK1,并促进肥胖相关血管疾病的发展。